SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 213 filers reported holding SEATTLE GENETICS INC in Q4 2014. The put-call ratio across all filers is 1.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $34,378,000 | +56.1% | 202,321 | +6.0% | 0.03% | +30.0% |
Q1 2020 | $22,024,000 | +12.1% | 190,886 | +11.0% | 0.02% | +42.9% |
Q4 2019 | $19,651,000 | +40.2% | 171,986 | +4.8% | 0.01% | +27.3% |
Q3 2019 | $14,014,000 | +25.5% | 164,099 | +1.7% | 0.01% | +22.2% |
Q2 2019 | $11,163,000 | -3.2% | 161,296 | +2.4% | 0.01% | -10.0% |
Q1 2019 | $11,535,000 | +29.0% | 157,492 | -0.2% | 0.01% | +11.1% |
Q4 2018 | $8,939,000 | -20.7% | 157,770 | +8.0% | 0.01% | -10.0% |
Q3 2018 | $11,267,000 | +44.6% | 146,097 | +24.5% | 0.01% | +42.9% |
Q2 2018 | $7,793,000 | +39.2% | 117,377 | +9.7% | 0.01% | +16.7% |
Q1 2018 | $5,599,000 | +0.1% | 106,975 | +2.3% | 0.01% | 0.0% |
Q4 2017 | $5,595,000 | +47.1% | 104,579 | +49.6% | 0.01% | +50.0% |
Q3 2017 | $3,804,000 | -0.9% | 69,918 | -5.8% | 0.00% | -20.0% |
Q2 2017 | $3,839,000 | -46.5% | 74,200 | -35.0% | 0.01% | -54.5% |
Q1 2017 | $7,172,000 | +51.9% | 114,097 | +27.5% | 0.01% | +57.1% |
Q4 2016 | $4,721,000 | -13.5% | 89,456 | -11.5% | 0.01% | -12.5% |
Q3 2016 | $5,457,000 | +27.1% | 101,033 | -4.9% | 0.01% | +14.3% |
Q2 2016 | $4,295,000 | +47.1% | 106,292 | +27.7% | 0.01% | +40.0% |
Q1 2016 | $2,920,000 | -44.0% | 83,206 | -28.4% | 0.01% | -44.4% |
Q4 2015 | $5,213,000 | +7.8% | 116,145 | -7.4% | 0.01% | 0.0% |
Q3 2015 | $4,835,000 | -18.5% | 125,384 | +2.3% | 0.01% | -25.0% |
Q2 2015 | $5,929,000 | +171.1% | 122,506 | +98.0% | 0.01% | +200.0% |
Q1 2015 | $2,187,000 | +53.0% | 61,863 | +39.1% | 0.00% | +33.3% |
Q4 2014 | $1,429,000 | -27.9% | 44,485 | -16.6% | 0.00% | -25.0% |
Q3 2014 | $1,983,000 | +48.4% | 53,323 | +52.6% | 0.00% | +33.3% |
Q2 2014 | $1,336,000 | -21.0% | 34,940 | -5.9% | 0.00% | -25.0% |
Q1 2014 | $1,691,000 | +23.2% | 37,121 | +7.9% | 0.00% | +33.3% |
Q4 2013 | $1,373,000 | +1.5% | 34,411 | +11.5% | 0.00% | -25.0% |
Q3 2013 | $1,353,000 | +38.8% | 30,874 | -0.4% | 0.00% | +33.3% |
Q2 2013 | $975,000 | – | 31,006 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 50,060,240 | $5,775,950,000 | 35.57% |
Lagoda Investment Management, L.P. | 72,969 | $8,419,000 | 9.97% |
Avidity Partners Management LP | 580,000 | $66,920,000 | 9.25% |
Arabesque Asset Management Ltd | 14,807 | $1,708,000 | 3.53% |
Boxer Capital, LLC | 400,000 | $46,152,000 | 3.15% |
Woodline Partners LP | 364,333 | $42,037,000 | 3.00% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 56,900 | $6,557,000 | 2.99% |
SECTORAL ASSET MANAGEMENT INC | 107,000 | $12,346,000 | 2.37% |
Capital International, Inc./CA/ | 1,197,659 | $138,186,000 | 2.33% |
Bain Capital Public Equity Management II, LLC | 169,641 | $19,573,000 | 2.29% |